Yujing Chi

2.7k total citations · 2 hit papers
39 papers, 2.0k citations indexed

About

Yujing Chi is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Yujing Chi has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Yujing Chi's work include Liver Disease Diagnosis and Treatment (12 papers), Pancreatic function and diabetes (10 papers) and Metabolism, Diabetes, and Cancer (6 papers). Yujing Chi is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Pancreatic function and diabetes (10 papers) and Metabolism, Diabetes, and Cancer (6 papers). Yujing Chi collaborates with scholars based in China, Romania and United States. Yujing Chi's co-authors include Weidong Yu, Junpei Wang, Di Wang, Jichun Yang, Jichun Yang, Ying Hu, Youfei Guan, Jing Li, Yulan Liu and Weiwei Jiang and has published in prestigious journals such as Hepatology, Diabetes and Scientific Reports.

In The Last Decade

Yujing Chi

37 papers receiving 2.0k citations

Hit Papers

Long Non-Coding RNA in the Pathogenesis of Cancers 2015 2026 2018 2022 2019 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujing Chi China 17 1.2k 650 553 425 285 39 2.0k
Lei Zhou China 28 948 0.8× 357 0.5× 389 0.7× 320 0.8× 112 0.4× 104 1.9k
Shaoqiang Lin China 28 2.1k 1.7× 308 0.5× 527 1.0× 485 1.1× 276 1.0× 48 3.2k
Dewei Ye China 26 1.4k 1.2× 297 0.5× 905 1.6× 534 1.3× 255 0.9× 49 2.9k
Qiaozhu Su United States 23 738 0.6× 249 0.4× 876 1.6× 378 0.9× 265 0.9× 50 1.9k
Jing Zeng China 22 677 0.6× 375 0.6× 450 0.8× 182 0.4× 96 0.3× 82 1.6k
Huihui Xu China 31 1.5k 1.3× 263 0.4× 407 0.7× 201 0.5× 196 0.7× 92 2.4k
Laura W. Schrum United States 29 1.2k 0.9× 414 0.6× 1.3k 2.3× 147 0.3× 450 1.6× 67 3.0k
Yonghui Yu China 26 1.2k 1.0× 453 0.7× 240 0.4× 151 0.4× 172 0.6× 67 2.1k
Yan‐Xiao Ji China 29 1.4k 1.1× 302 0.5× 1.5k 2.6× 260 0.6× 225 0.8× 50 3.1k

Countries citing papers authored by Yujing Chi

Since Specialization
Citations

This map shows the geographic impact of Yujing Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujing Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujing Chi more than expected).

Fields of papers citing papers by Yujing Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujing Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujing Chi. The network helps show where Yujing Chi may publish in the future.

Co-authorship network of co-authors of Yujing Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Yujing Chi. A scholar is included among the top collaborators of Yujing Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujing Chi. Yujing Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Rufeng, Rui Xiang, Wenjun Liu, et al.. (2025). Hepatic ENTPD5 Is Critical for Maintaining Metabolic Homeostasis and Promoting Brown Adipose Tissue Thermogenesis. Advanced Science. 12(40). e03603–e03603.
2.
Zhang, Han, Yujing Chi, Jiayi Li, et al.. (2024). Enhanced adsorption of radioactive cesium from nuclear wastewater using ZIF-67 laminated 2D MXene Ti3C2. Separation and Purification Technology. 355. 129590–129590. 11 indexed citations
3.
4.
Huang, Jiaofeng, et al.. (2024). Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease. Scientific Reports. 14(1). 5923–5923. 6 indexed citations
5.
Han, Yan, Rui Xiang, Xin Li, et al.. (2024). Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis. Signal Transduction and Targeted Therapy. 9(1). 214–214. 3 indexed citations
6.
Wang, Yu, Yujing Chi, Wenwen Liu, et al.. (2023). Construction of S-scheme p-n heterojunction between protonated g-C3N4 and α-MnS nanosphere for photocatalytic H2O2 production and in situ degradation of oxytetracycline. Journal of environmental chemical engineering. 11(3). 109968–109968. 14 indexed citations
7.
Wang, Yu, et al.. (2023). Hydroxyl modified nano calcium phosphate, a novel adsorbent for denitrogenation of fuel: Synthesis, characterization and adsorptive performance for quinoline. Journal of environmental chemical engineering. 11(5). 110374–110374. 3 indexed citations
8.
Li, Jing, Xin Li, Di Wang, et al.. (2023). Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation. Metabolism. 146. 155661–155661. 5 indexed citations
9.
Li, Jing, Han Yan, Rui Xiang, et al.. (2022). ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism. Frontiers in Physiology. 13. 918042–918042. 12 indexed citations
10.
Xiang, Rui, Chengqing Hu, Zhenzhen Chen, et al.. (2022). Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis. Metabolism. 136. 155292–155292. 14 indexed citations
11.
Yan, Han, Yuhong Meng, Xin Li, et al.. (2022). FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase. Metabolism. 139. 155372–155372. 12 indexed citations
12.
Yang, Xiao, Yuan Cheng, Jingyi Zhou, et al.. (2022). Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes. Advanced Science. 9(8). e2104472–e2104472. 31 indexed citations
13.
Zhang, Yujun, Ying Hu, Jing Li, et al.. (2017). Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. Hepatobiliary & pancreatic diseases international. 16(1). 65–79. 10 indexed citations
14.
Hu, Ying, You Peng, Yujing Chi, et al.. (2016). Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury. Chinese Medical Journal. 129(2). 174–180. 13 indexed citations
15.
Huang, Zhu, Tong-Song Wang, Yuechao Zhao, et al.. (2014). Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization. Molecular and Cellular Endocrinology. 388(1-2). 20–31. 9 indexed citations
16.
Shi, Jia, Zhenzhen Chen, Jing Li, et al.. (2014). FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury. Journal of Molecular and Cellular Cardiology. 74. 173–182. 29 indexed citations
18.
Wang, Chunjiong, Yujing Chi, Jing Li, et al.. (2013). FAM3A Activates PI3K p110α/Akt Signaling to Ameliorate Hepatic Gluconeogenesis and Lipogenesis. Hepatology. 59(5). 1779–1790. 98 indexed citations
19.
Shi, Jia, Chunjiong Wang, Zhenzhen Chen, et al.. (2013). FAM3A is a target gene of peroxisome proliferator-activated receptor gamma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(8). 4160–4170. 30 indexed citations
20.
Yang, Jichun, Yujing Chi, Brant Burkhardt, Youfei Guan, & Bryan A. Wolf. (2010). Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutrition Reviews. 68(5). 270–279. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026